Generate Biomedicines 宣布,公司当前持有的现金、现金等价物以及有价证券,已足够支持其现有运营计划,直至2028年上半年。这一资金储备状况,为公司未来的研发与业务拓展提供了坚实的财务基础。
Generate Biomedicines 宣布,公司当前持有的现金、现金等价物以及有价证券,已足够支持其现有运营计划,直至2028年上半年。这一资金储备状况,为公司未来的研发与业务拓展提供了坚实的财务基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.